Lisata Therapeutics sues Kuva Labs, cuts 72% of workforce
Lisata Therapeutics has filed a lawsuit against Kuva Labs Inc. and its subsidiary in Delaware, seeking damages and a $2 million termination fee following the termination of their merger agreement. Concurrently, Lisata has reduced its workforce by approximately 72% to cut operating expenses and …